Hutchmed Drc Stock Price History

HCM Stock  USD 17.41  0.05  0.29%   
Below is the normalized historical share price chart for HUTCHMED DRC extending back to March 17, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of HUTCHMED DRC stands at 17.41, as last reported on the 26th of November, with the highest price reaching 17.71 and the lowest price hitting 17.29 during the day.
IPO Date
17th of March 2016
200 Day MA
17.9852
50 Day MA
18.759
Beta
0.746
 
Yuan Drop
 
Covid
If you're considering investing in HUTCHMED Stock, it is important to understand the factors that can impact its price. As of now, HUTCHMED Stock is not too volatile. HUTCHMED DRC holds Efficiency (Sharpe) Ratio of 0.0187, which attests that the entity had a 0.0187% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for HUTCHMED DRC, which you can use to evaluate the volatility of the firm. Please check out HUTCHMED DRC's market risk adjusted performance of (0.01), and Risk Adjusted Performance of 0.0081 to validate if the risk estimate we provide is consistent with the expected return of 0.0593%.
  
HUTCHMED Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0187

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskHCMHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.17
  actual daily
28
72% of assets are more volatile

Expected Return

 0.06
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average HUTCHMED DRC is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HUTCHMED DRC by adding it to a well-diversified portfolio.
Price Book
4.0094
Enterprise Value Ebitda
36.807
Price Sales
4.975
Shares Float
515.9 M
Wall Street Target Price
28.5308

HUTCHMED DRC Stock Price History Chart

There are several ways to analyze HUTCHMED Stock price data. The simplest method is using a basic HUTCHMED candlestick price chart, which shows HUTCHMED DRC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 23, 202421.35
Lowest PriceSeptember 10, 202416.03

HUTCHMED DRC November 26, 2024 Stock Price Synopsis

Various analyses of HUTCHMED DRC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell HUTCHMED Stock. It can be used to describe the percentage change in the price of HUTCHMED DRC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of HUTCHMED Stock.
HUTCHMED DRC Accumulation Distribution 969.18 
HUTCHMED DRC Price Action Indicator(0.06)
HUTCHMED DRC Price Daily Balance Of Power 0.12 
HUTCHMED DRC Price Rate Of Daily Change 1.00 

HUTCHMED DRC November 26, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in HUTCHMED Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use HUTCHMED DRC intraday prices and daily technical indicators to check the level of noise trading in HUTCHMED Stock and then apply it to test your longer-term investment strategies against HUTCHMED.

HUTCHMED Stock Price History Data

The price series of HUTCHMED DRC for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 5.32 with a coefficient of variation of 8.24. Under current investment horizon, the daily prices are spread out with arithmetic mean of 18.4. The median price for the last 90 days is 17.95. The company completed 1:1 stock split on 30th of May 2019.
OpenHighLowCloseVolume
11/25/2024 17.29  17.71  17.29  17.41  40,867 
11/22/2024 17.43  17.60  17.27  17.36  26,034 
11/21/2024 17.81  17.82  17.52  17.68  61,886 
11/20/2024 17.90  18.44  17.80  17.96  94,527 
11/19/2024 16.64  16.76  16.58  16.75  36,493 
11/18/2024 16.84  16.89  16.63  16.83  37,923 
11/15/2024 16.86  17.18  16.60  16.74  67,235 
11/14/2024 16.91  17.02  16.68  16.85  46,106 
11/13/2024 17.21  17.35  16.84  17.04  70,425 
11/12/2024 17.51  17.77  17.39  17.48  167,667 
11/11/2024 17.72  17.87  17.40  17.64  86,606 
11/08/2024 18.10  18.18  17.70  17.95  85,779 
11/07/2024 18.52  18.81  18.43  18.70  54,417 
11/06/2024 18.70  18.80  18.24  18.33  98,704 
11/05/2024 18.75  18.75  18.44  18.62  42,101 
11/04/2024 18.63  18.65  18.34  18.38  65,870 
11/01/2024 18.74  19.08  18.58  18.63  68,632 
10/31/2024 18.41  18.57  17.95  18.00  127,065 
10/30/2024 19.16  19.23  18.80  18.95  91,982 
10/29/2024 20.02  20.07  19.50  19.60  96,857 
10/28/2024 20.85  20.85  20.47  20.65  97,678 
10/25/2024 20.82  21.25  20.80  20.85  55,898 
10/24/2024 20.94  20.94  20.31  20.55  84,566 
10/23/2024 21.25  21.50  21.08  21.35  69,230 
10/22/2024 20.88  21.32  20.88  21.28  57,766 
10/21/2024 20.70  21.20  20.70  20.85  69,733 
10/18/2024 20.16  20.96  20.16  20.90  343,135 
10/17/2024 19.89  19.98  19.32  19.42  79,582 
10/16/2024 19.40  19.99  19.27  19.81  170,483 
10/15/2024 19.18  19.18  18.57  18.81  112,133 
10/14/2024 19.58  19.58  19.25  19.49  75,352 
10/11/2024 19.77  19.80  19.27  19.49  60,902 
10/10/2024 20.14  20.38  19.51  19.91  107,276 
10/09/2024 19.94  20.14  19.77  20.08  88,220 
10/08/2024 20.42  20.86  20.38  20.61  142,098 
10/07/2024 21.02  21.20  20.57  20.96  132,661 
10/04/2024 21.10  21.16  20.52  21.01  339,794 
10/03/2024 19.90  20.05  19.57  19.95  98,443 
10/02/2024 20.50  21.10  20.42  20.82  323,836 
10/01/2024 19.69  20.01  19.36  20.00  165,551 
09/30/2024 20.00  20.00  19.13  19.53  231,437 
09/27/2024 19.13  19.44  18.86  19.04  119,971 
09/26/2024 18.04  18.51  18.04  18.42  86,833 
09/25/2024 17.67  17.77  17.44  17.49  89,413 
09/24/2024 17.01  17.48  16.98  17.35  92,021 
09/23/2024 17.00  17.09  16.50  16.50  74,091 
09/20/2024 17.27  17.48  17.13  17.38  103,864 
09/19/2024 16.80  17.19  16.80  16.81  40,371 
09/18/2024 16.39  16.47  16.19  16.32  40,341 
09/17/2024 16.50  16.64  16.25  16.30  28,665 
09/16/2024 17.12  17.12  16.48  16.53  63,805 
09/13/2024 17.20  17.49  17.20  17.29  64,459 
09/12/2024 16.75  16.94  16.60  16.68  33,953 
09/11/2024 16.50  16.84  16.50  16.81  67,382 
09/10/2024 16.75  17.70  15.82  16.03  118,201 
09/09/2024 17.38  17.54  17.25  17.29  37,400 
09/06/2024 17.56  17.56  17.26  17.38  42,452 
09/05/2024 17.75  18.13  17.64  17.65  65,708 
09/04/2024 17.55  17.76  17.24  17.42  74,772 
09/03/2024 17.20  17.93  17.20  17.44  87,857 
08/30/2024 17.63  17.65  17.42  17.45  81,117 

About HUTCHMED DRC Stock history

HUTCHMED DRC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HUTCHMED is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HUTCHMED DRC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HUTCHMED DRC stock prices may prove useful in developing a viable investing in HUTCHMED DRC
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people.

HUTCHMED DRC Quarterly Net Working Capital

693.81 Million

HUTCHMED DRC Stock Technical Analysis

HUTCHMED DRC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of HUTCHMED DRC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of HUTCHMED DRC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

HUTCHMED DRC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for HUTCHMED DRC's price direction in advance. Along with the technical and fundamental analysis of HUTCHMED Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HUTCHMED to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(0.25)
Revenue Per Share
3.575
Quarterly Revenue Growth
(0.43)
Return On Assets
(0.06)
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.